Syngene International Ltd. | Large-cap | Healthcare
₹642.65
-0.47%
| Syngene Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 36.4B
Gross Profit 27.0B 74.12%
Operating Income 6.1B 16.78%
Net Income 5.0B 13.62%

Balance Sheet Metrics

Total Assets 68.0B
Total Liabilities 20.7B
Shareholders Equity 47.3B
Debt to Equity 0.44

Cash Flow Metrics

Operating Cash Flow 5.0B
Free Cash Flow 4.0B

Revenue & Profitability Trend

Syngene Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 36.4B 33.7B 30.8B 25.1B 20.9B
Cost of Goods Sold 9.4B 9.3B 8.6B 7.5B 5.3B
Gross Profit 27.0B 24.4B 22.2B 17.6B 15.6B
Operating Expenses 6.7B 5.8B 5.0B 3.8B 3.3B
Operating Income 6.1B 6.5B 6.2B 4.3B 3.9B
Pre-tax Income 6.6B 6.2B 5.9B 4.8B 4.7B
Income Tax 1.6B 1.1B 1.3B 886.0M 643.0M
Net Income 5.0B 5.1B 4.6B 4.0B 4.0B
EPS (Diluted) - ₹12.69 ₹11.51 ₹9.82 ₹10.11

Income Statement Trend

Syngene Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 22.9B 19.6B 24.3B 22.1B 18.1B
Non-Current Assets 45.1B 41.9B 34.1B 33.6B 30.8B
Total Assets 68.0B 61.5B 58.3B 55.6B 48.8B
Liabilities
Current Liabilities 14.0B 11.4B 11.9B 12.3B 11.3B
Non-Current Liabilities 6.7B 7.5B 10.2B 10.4B 9.3B
Total Liabilities 20.7B 18.9B 22.1B 22.7B 20.6B
Equity
Total Shareholders Equity 47.3B 42.6B 36.2B 33.0B 28.2B

Balance Sheet Composition

Syngene Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 5.0B 5.1B 4.6B 4.0B 4.0B
Operating Cash Flow 5.0B 7.8B 2.4B 2.0B 4.3B
Investing Activities
Capital Expenditures -7.6B -4.7B -5.1B -4.8B -4.4B
Investing Cash Flow -7.9B -5.6B -7.0B -6.4B -6.8B
Financing Activities
Dividends Paid -503.0M -503.0M -401.0M - -
Financing Cash Flow -327.0M -956.0M -3.0B -58.0M 900.0M
Free Cash Flow 4.0B 5.3B 3.1B 1.1B 2.5B

Cash Flow Trend

Syngene Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 51.42
Forward P/E 37.75
Price to Book 5.41
Price to Sales 7.02
PEG Ratio 37.75

Profitability Ratios

Profit Margin 13.62%
Operating Margin 23.78%
Return on Equity 11.05%
Return on Assets 5.90%

Financial Health

Current Ratio 1.64
Debt to Equity 12.23
Beta 0.15

Per Share Data

EPS (TTM) ₹12.37
Book Value per Share ₹117.59
Revenue per Share ₹90.66

Financial data is updated regularly. All figures are in the company's reporting currency.